NovaBay Pharmaceuticals
-$0.0581 (-8.65%) Today
+$0.0212 (+3.45%) As of 9:11 AM UTC after-hours
Why Robinhood?
You can buy or sell NBY and other stocks, options, and ETFs commission-free!
About NBY
NovaBay Pharmaceuticals, Inc. engages in development of products for eye care. Its products include Avenova, NeutroPhase, and CelleRx.
CEO
Justin M. Hall
Employees
25
Headquarters
Emeryville, California
Founded
2000
NBY Key Statistics
Market Cap
27.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
560.23K
High Today
$0.6898
Low Today
$0.615
Open Price
$0.6721
Volume
510.55K
52 Week High
$1.94
52 Week Low
$0.515
NBY Earnings
-$0.15
-$0.11
-$0.06
-$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.04 per share
Actual
-$0.04 per share